Laroprovstat

DRUG2 trials

Sponsors

AstraZeneca

Conditions

Healthy ParticipantsHypercholesterolaemia

Phase 1

A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of AZD4954 and Vice Versa in Healthy Adults

CompletedNCT07513571

AstraZenecaHealthy Participants

Start: 2026-04-10End: 2026-07-08Updated: 2026-08-04

Phase 3

A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.

RecruitingNCT07619131

AstraZenecaHypercholesterolaemia

Start: 2026-08-12End: 2027-07-30Target: 600Updated: 2026-09-10